Russell Frank Company
AXDX icon

Russell Frank Company’s Accelerate Diagnostics AXDX Stock Holding History

Russell Frank Company’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-249
Closed -$64K – 2993
2015
Q2 		$64K Buy
+249
New +$59.5K ﹤0.01% 2948
2013
Q4 		– Sell
-306
Closed -$34K – 2807
2013
Q3 		$34K Buy
306
+23
+8% +$2.05K ﹤0.01% 3173
2013
Q2 		$23K Buy
+283
New +$21K ﹤0.01% 2981

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Private Wealth Advisors
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Obermeyer Wealth Partners
Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return

Russell Frank Company's AXDX Position: Q3 2015 in Review

Russell Frank Company sold out of Accelerate Diagnostics (AXDX) in Q3 2015, closing a stake of 249 shares — an estimated $64K sold.

Russell Frank Company first reported a position in AXDX in Q2 2013 and held it in 3 quarters. The position peaked at $64K in Q2 2015. 88 funds tracked by Wall St. Rank hold AXDX as of Q3 2015.

  • Russell Frank Company reported no remaining Accelerate Diagnostics position as of Q3 2015 after selling out during the quarter.
  • Russell Frank Company sold 249 Accelerate Diagnostics shares in Q3 2015, an estimated $64K.
  • Russell Frank Company first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 3 quarters.
  • Russell Frank Company's Accelerate Diagnostics position peaked at $64K in Q2 2015.
  • 88 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2015.

Based on Russell Frank Company's 13F filing for Q3 2015, filed 23 Oct 2015.